Shares of hVIVO plc (LON:HVO – Get Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 28.25 ($0.37) and traded as low as GBX 26.70 ($0.35). hVIVO shares last traded at GBX 27.30 ($0.36), with a volume of 10,117,770 shares traded.
hVIVO Price Performance
The stock has a market capitalization of £185.74 million, a PE ratio of 910.00 and a beta of 0.97. The company has a quick ratio of 1.16, a current ratio of 1.61 and a debt-to-equity ratio of 33.86. The stock’s 50-day moving average is GBX 28.75 and its 200 day moving average is GBX 28.24.
Insider Activity
In related news, insider Cathal Friel sold 21,159,176 shares of the stock in a transaction on Tuesday, July 23rd. The stock was sold at an average price of GBX 29 ($0.38), for a total transaction of £6,136,161.04 ($8,030,573.28). 14.03% of the stock is currently owned by corporate insiders.
hVIVO Company Profile
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Read More
- Five stocks we like better than hVIVO
- High Flyers: 3 Natural Gas Stocks for March 2022
- Why Fastenal Stock Could Hit New Highs After Strong Q3 Results
- 3 Small Caps With Big Return Potential
- Why Eli Lilly Stock Is Soaring—and How It Plans to Stay on Top
- How to Capture the Benefits of Dividend Increases
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.